Even though discounted playing cards can help reduce the load of high drug fees in the short-term, they don't address the systemic challenges driving up prescription costs inside the U.S. Broader plan changes could deal with the foundation leads to of growing drug selling prices, such as deficiency of transparency in pricing plus the role of interm